A powerful feature of CT-FAST is the determination of re-evaluated supply strategies for ongoing trials.
Taking into account data collected through the IVR system, CT-FAST Refine can:
Learn from past trials to improve clinical assumptions such as, enrollment rates, dropout rates, visit windows, strata and titration probabilities
Decrease the uncertainty for subsequent forecasts and therefore potentially reducing safety stocks and production overages, while maintaining a high confidence level
Adjust IVRS inventory management rules (trigger levels, re-supply quantities, etc.)
